Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries.

Journal: Vaccines

Volume: 9

Issue: 5

Year of Publication: 

Affiliated Institutions:  School of Social Science, Universiti Sains Malaysia, Gelugor , Malaysia. Disease Control Coordination, São Paulo State Health Department, São Paulo -, Brazil. Centre for Community Health Studies (ReaCH), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur , Malaysia. Department of Health Science and Biostatistics, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, VIC , Australia. ASEAN Institute for Health Development, Mahidol University, Nakhon Pathom , Thailand. Public Health Foundation, Bangladesh (PHF, BD), Dhaka , Bangladesh. Research Unit on Communicable Diseases, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou BP , Benin. Kinshasa School of Public Health, University of Kinshasa, Kinshasa , Democratic Republic of the Congo. Uganda Public Health Fellowship Program, Loudel Towers, Level , Kampala, Uganda. University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC , USA. International Center of Excellence in Research, Faculty of Medicine and OdontoStomatology, Bamako, Mali. Global Health Institute, University of Antwerp, Antwerp, Belgium. Faculty of Medicine, Universiti Malaya, Kuala Lumpur , Malaysia.

Abstract summary 

Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted cross-sectional online surveys to investigate COVID-19 vaccine acceptance across nine Low- and Middle-Income Countries (LMICs; = 10,183), assuming vaccine effectiveness at 90% and 95%. The prevalence of vaccine acceptance increased from 76.4% (90% effectiveness) to 88.8% (95% effectiveness). Considering a 90% effective vaccine, Malaysia, Thailand, Bangladesh, and five African countries (Democratic Republic of Congo, Benin, Uganda, Malawi, and Mali) had lower acceptance odds compared to Brazil. Individuals who perceived taking the vaccine as important to protect themselves had the highest acceptance odds (aOR 2.49) at 95% effectiveness.Vaccine acceptance was also positively associated with COVID-19 knowledge, worry/fear regarding COVID-19, higher income, younger age, and testing negative for COVID-19. However, chronic disease and female gender reduced the odds for vaccine acceptance. The main reasons underpinning vaccine refusal were fear of side effects (41.2%) and lack of confidence in vaccine effectiveness (15.1%). Further research is needed to identify country-specific reasons for vaccine hesitancy in order to develop mitigation strategies that would ensure high and equitable vaccination coverage across LMICs.

Authors & Co-authors:  Bono Suzanna Awang SA Faria de Moura Villela Edlaine E Siau Ching Sin CS Chen Won Sun WS Pengpid Supa S Hasan M Tasdik MT Sessou Philippe P Ditekemena John D JD Amodan Bob Omoda BO Hosseinipour Mina C MC Dolo Housseini H Siewe Fodjo Joseph Nelson JN Low Wah Yun WY Colebunders Robert R

Study Outcome 

Source Link: Visit source

Statistics
Citations :  WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 3 March 2021)]; Available online: https://covid19.who.int/
Authors :  14
Identifiers
Doi : 515
SSN : 2076-393X
Study Population
Female
Mesh Terms
Other Terms
Africa;Bangladesh;Brazil;COVID-19;LMICs;Malaysia;Thailand;healthcare worker;psychological distress;vaccine acceptance
Study Design
Study Approach
Country of Study
Uganda
Publication Country
Switzerland